Depression and Anxiety Trial, Recruiting (NCT07432945)

Depression and Anxiety Trial, Recruiting NCT07432945 Sponsor: Ruhr University of Bochum Condition: Depression and Anxiety

Printed from Voxsanity (voxsanity.com.au) — NCT07432945 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Depression And Anxiety

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who have a fear of spiders (which may meet the criteria for arachnophobia)

Who may not be able to join:

People who score at level 10 or higher on an initial behavioural approach test (a standard assessment measuring how close a person can get to a spider — confirm with trial site)
People who have a mental health condition that is more severe or disabling than a fear of spiders
People who have a serious ongoing or acute physical health condition that could interfere with exposure-based treatment, such as certain heart or cardiovascular conditions
People who have a heart-related condition, including a pacemaker, slow heart rate (bradycardia), high blood pressure, or irregular heartbeat
People who are currently receiving psychological, psychiatric, neurological, or medication-based treatment of any kind
People who have a current problem with drug or alcohol misuse
People who are pregnant
People who have an allergy to insect stings

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 12 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Armin Zlomuzica, Prof. Dr., Ruhr University of Bochum

Phone: (+49)02343228469

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07432945

Sponsor: Ruhr University of Bochum

Phase: Not Applicable

Status: Recruiting

Condition: Depression and Anxiety

Trial contact: (+49)02343228469

More information: https://clinicaltrials.gov/study/NCT07432945

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who have a fear of spiders (which may meet the criteria for arachnophobia)

Who may not be able to join:

People who score at level 10 or higher on an initial behavioural approach test (a standard assessment measuring how close a person can get to a spider — confirm with trial site)
People who have a mental health condition that is more severe or disabling than a fear of spiders
People who have a serious ongoing or acute physical health condition that could interfere with exposure-based treatment, such as certain heart or cardiovascular conditions
People who have a heart-related condition, including a pacemaker, slow heart rate (bradycardia), high blood pressure, or irregular heartbeat
People who are currently receiving psychological, psychiatric, neurological, or medication-based treatment of any kind
People who have a current problem with drug or alcohol misuse
People who are pregnant
People who have an allergy to insect stings

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 12 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Ruhr University of Bochum

Registry

ClinicalTrials.gov

Start date

26 February 2026

Est. completion

31 December 2026

Where this trial is recruiting

🇩🇪 Germany

Primary endpoints

Behavioral Approach Test (BAT); Subjective fear; Subjective disgust; Heart Rate

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 12 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov